Categories: News

Nippon Express Launches Ultra-low Temperature-controlled Logistics Service for Pharmaceutical Industry

TOKYO, June 9, 2022 /PRNewswire/ — Nippon Express Co., Ltd. (hereinafter “Nippon Express”), a group company of Nippon Express Holdings, Inc., launched on May 30 a logistics service capable of handling goods requiring ultra-low temperatures (-20 C to -85 C) for the pharmaceutical industry.

Logo: https://kyodonewsprwire.jp/img/202206072182-O1-1zA70963

Photo: Products to be handled (examples)
https://kyodonewsprwire.jp/img/202206072182-O2-zds69HQG

Photo: Envisioned uses for service
https://kyodonewsprwire.jp/img/202206072182-O3-9s8evO6B

As a priority approach for the core business growth strategy outlined in the “NX Group Business Plan 2023 – Dynamic Growth,” the NX Group has positioned the pharmaceutical industry as a priority industry and is moving forward in developing quality control systems and improving its business infrastructure both inside and outside Japan in accordance with the Good Distribution Practices (GDP) established for pharmaceuticals.

Nippon Express has heretofore provided a pharmaceutical distribution platform with strict temperature control in two ranges — 2 C to 8 C (refrigerated) and 15 C to 25 C (constant temperature) — and has recently introduced innovations that will enable it henceforth to handle goods requiring ultra-low temperatures in the -20 C to -85 C range.

These enhancements will permit ultra-low temperature storage and transport of pharmaceutical products at the research and development stage and in the formulation process. Nippon Express is thus able to offer temperature-controlled logistics services for a broad spectrum of pharmaceutical commodities, including raw materials, intermediates and active pharmaceutical ingredients as well as finished products.

Going forward, Nippon Express will continue expanding and developing its services globally to meet demand for increasingly sophisticated and diversified end-to-end pharmaceutical logistics services.

Dedicated website for pharmaceutical logistics services
URL: https://www.nipponexpress.com/industries/pharma/

Nippon Express website: https://www.nipponexpress.com/

NX Group’s official LinkedIn account:
https://www.linkedin.com/company/nippon-express-group/

View original content:https://www.prnewswire.com/news-releases/nippon-express-launches-ultra-low-temperature-controlled-logistics-service-for-pharmaceutical-industry-301564682.html

SOURCE Nippon Express Holdings, Inc.

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

1 hour ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

15 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

16 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

16 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

17 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

19 hours ago